Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Negative, Chronic Hepatitis B Patients: A Global Phase 3 Study
| Autor: | Mani Subramanian, Audrey H. Lau, Namiki Izumi, John F. Flaherty, Anuj Gaggar, Calvin Q. Pan, Edward Gane, Akash Shukla, Vithika Suri, Henry L. Chan, Maurizia Rossana Brunetto, Wan-Long Chuang, Patrick Marcellin, Harry L.A. Janssen, M F Osipenko, Young-Suk Lim, Huy N. Trinh, Alain Chan, Sang Hoon Ahn, Wai-Kay Seto, Maria Buti, Mustafa Kemal Çelen |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Hepatology Tenofovir business.industry 030106 microbiology Gastroenterology Phases of clinical research Tenofovir alafenamide 03 medical and health sciences 0302 clinical medicine Hbeag negative Chronic hepatitis 030220 oncology & carcinogenesis Internal medicine Medicine business medicine.drug |
| Zdroj: | Gastroenterology. 152:S1086 |
| ISSN: | 0016-5085 |
| DOI: | 10.1016/s0016-5085(17)33661-2 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|